Big Bold Health Secures Series B Funding for Immuno-Rejuvenation Advances
Big Bold Health, a pioneering company in the health supplements industry, has recently announced a successful Series B funding round. This significant investment is led by S2G Investments, Starshot Ventures, and Andas, further solidifying the company’s position in the natural wellness products market.
Big Bold Health focuses on developing products that aim to rejuvenate the immune system, leveraging the power of nature and the body’s innate defenses. The company offers a range of supplements, including phytonutrient blends from Himalayan Tartary Buckwheat, omega-3 products sourced from wild Alaskan fish, and formulations designed to support gut health with prebiotics and probiotics.
The latest funding round marks a significant milestone for Big Bold Health, which was founded in 2018 by Dr. Jeffrey Bland, a renowned figure in the field of functional medicine. Dr. Bland’s vision for the company is to harness the potential of natural ingredients to promote whole-body wellbeing, particularly through the concept of Immuno-Rejuvenation (IR).
Immuno-Rejuvenation is a pioneering approach that aims to build resilience into the immune response by rejuvenating cells and rebalancing immune function. This approach is grounded in extensive research on the nutritional profile of Himalayan Tartary Buckwheat, which is rich in immune-active plant nutrients such as polyphenols, including quercetin and rutin. Additionally, the company’s products incorporate omega-3 fats and probiotics, which are identified as promising nutrients for rejuvenating immunity and combating cellular aging.
The funding from S2G Investments, Starshot Ventures, and Andas will enable Big Bold Health to further develop its product line and expand its reach in the health supplements market. This investment underscores the growing interest in natural wellness products and the potential of Immuno-Rejuvenation to make a significant impact on public health.
Big Bold Health’s commitment to scientific research is evident in its comprehensive studies on the effects of its products. For instance, the company has measured the impact of its HTB Rejuvenate product on over 850,000 epigenetic markers to understand the connections between aging, immunity, and the key compounds of HTB. This rigorous scientific approach sets Big Bold Health apart in the industry and positions it for continued growth and success.
The company’s recent announcement of the first USA-farmed 100% organic Himalayan Tartary Buckwheat sprout powder further demonstrates its commitment to innovation and quality. This single ingredient supports gut and microbiome health and immune performance, aligning with the company’s overarching mission to promote whole-body wellbeing.
With this latest funding round, Big Bold Health is poised to continue its pioneering work in the health supplements industry, leveraging the power of natural ingredients to promote immune rejuvenation and overall health. The investment from S2G Investments, Starshot Ventures, and Andas is a testament to the company’s potential to make a significant impact in the natural wellness products market.
See more funded startups in USA.